Ecstatic Integration

Ecstatic Integration

Therapists on psychedelic trials express concerns over safety and ethics

They deserve to be listened to

Jules Evans's avatar
Jules Evans
May 16, 2026
∙ Paid

Psychedelic drug companies are suddenly doing great. The FDA is granting them National Priority Vouchers, President Trump has backed them from the Oval Office, stock prices have soared, big pharma is on a shopping spree. This is very good news for those with equity in psychedelic drug companies, and it’s a hopeful moment for those who believe in the med…

User's avatar

Continue reading this post for free, courtesy of Jules Evans.

Or purchase a paid subscription.
© 2026 The Challenging Psychedelic Experiences Project · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture